These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2304308)

  • 1. [Statistical evaluation of determinants of progression of superficial bladder cancer by proportional hazards model].
    Takashi M; Sakata T; Murase T; Takagi Y; Nagai T; Sahashi M; Shimoji T; Miyake K; Hamajima N
    Nihon Hinyokika Gakkai Zasshi; 1990 Jan; 81(1):116-21. PubMed ID: 2304308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate evaluation of prognostic determinants in bladder cancer patients.
    Takashi M; Murase T; Mizuno S; Hamajima N; Ohno Y
    Urol Int; 1987; 42(5):368-74. PubMed ID: 3433584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation on recurrent and evolutionary factors in superficial bladder cancer].
    Kawashima K; Imai K
    Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1103-9. PubMed ID: 8345728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grade 3 bladder cancer with lamina propria invasion (pT1): characteristics of tumor and clinical course.
    Takashi M; Sakata T; Murase T; Hamajima N; Miyake K
    Nagoya J Med Sci; 1991 Mar; 53(1-4):1-8. PubMed ID: 1805133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor enzymes and prognosis in transitional cell carcinoma of the bladder: prediction of risk of progression in patients with superficial disease.
    Deshpande N; Mitchell IP; Hayward SW; Love S; Towler JM
    J Urol; 1991 Nov; 146(5):1247-51. PubMed ID: 1942272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Statistical analysis of recurrent factors in superficial bladder cancer. Natural history of superficial bladder cancer].
    Kobashi K
    Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1188-96. PubMed ID: 8355435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of factors affecting reccurence and prognosis of superficial bladder cancer--study of 800 patients--].
    Yamada T; Tsuchiya T; Kamei S; Yoh M; Nishino Y; Nishida Y; Taniguchi M; Nagai T; Takeuchi T; Ehara H; Takahashi Y; Deguchi T
    Nihon Hinyokika Gakkai Zasshi; 2006 Jan; 97(1):33-41. PubMed ID: 16485552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
    Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
    J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infiltrative lamina propria invasion pattern as an independent predictor for cancer-specific and overall survival of instillation treatment-naïve stage T1 high-grade urothelial bladder cancer.
    Otto W; van Rhijn BW; Breyer J; Bertz S; Eckstein M; Mayr R; Lausenmeyer EM; Denzinger S; Burger M; Hartmann A
    Int J Urol; 2018 May; 25(5):442-449. PubMed ID: 29473226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of grade 3 superficial bladder cancer].
    Shinohara M; Inoue Y; Itakura H; Munakata A; Kinoshita K
    Nihon Hinyokika Gakkai Zasshi; 1996 Jun; 87(6):892-9. PubMed ID: 8753007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microstaging of pT1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pT1 subcategory).
    Sözen S; Akbal C; Sökmensüer C; Ekici S; Ozen H
    Urol Int; 2002; 69(3):200-6. PubMed ID: 12372888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.
    Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Búcar S; Salinas D; Orsola I
    Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multivariate evaluation of survival factors and postoperative adjuvant chemotherapy in patients with bladder cancer treated by radical cystectomy].
    Takashi M; Murase T; Aota Y; Nagai T; Kinjo T; Sabashi M; Shimoji T; Miyake K; Hamajma N; Mizuno S
    Hinyokika Kiyo; 1988 Aug; 34(8):1377-81. PubMed ID: 2461643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer.
    Solsona E; Iborra I; Dumont R; Rubio-Briones J; Casanova J; Almenar S
    J Urol; 2000 Sep; 164(3 Pt 1):685-9. PubMed ID: 10953125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion.
    Kaubisch S; Lum BL; Reese J; Freiha F; Torti FM
    J Urol; 1991 Jul; 146(1):28-31. PubMed ID: 2056599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting recurrence and progression in superficial bladder tumours.
    Kurth KH; Denis L; Bouffioux C; Sylvester R; Debruyne FM; Pavone-Macaluso M; Oosterlinck W
    Eur J Cancer; 1995 Oct; 31A(11):1840-6. PubMed ID: 8541110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological study of the 1973 who classification and the WHO/ISUP classification in pTa bladder carcinoma].
    Ishida R; Tsuzuki T; Yoshida S; Shiota T; Nisikimi T; Yamada H; Yokoi K; Kobayashi H
    Nihon Hinyokika Gakkai Zasshi; 2010 May; 101(4):609-14. PubMed ID: 20535989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
    BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors.
    Alkhateeb SS; Van Rhijn BW; Finelli A; van der Kwast T; Evans A; Hanna S; Vajpeyi R; Fleshner NE; Jewett MA; Zlotta AR
    J Urol; 2010 Jul; 184(1):81-6. PubMed ID: 20478593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.